[引用][C] OUTCOMES IN LATER‐LINES OF THERAPY FOR RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: RESULTS FROM THE INTERNATIONAL …
Background: Follicular lymphoma (FL) patients may receive many lines of treatment (LoTs)
to maintain disease control. Current clinical outcomes in later LoTs (≥ 3 rd) are not well …
to maintain disease control. Current clinical outcomes in later LoTs (≥ 3 rd) are not well …
[HTML][HTML] Treatment patterns and outcomes in relapsed/refractory follicular lymphoma: results from the international SCHOLAR-5 study
The SCHOLAR-5 study examines treatment patterns and outcomes of real-world follicular
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
lymphoma (FL) patients on 3 rd line of treatment (LoT) or higher, for whom existing data are …
[HTML][HTML] Treatment Patterns and Outcomes Among Patients with Relapsed/Refractory Follicular Lymphoma Treated in Routine Clinical Practice in the US with Three or …
JT Ta, S Arndorfer, C Julian, M Wu, D Lai, S Shapouri - Blood, 2021 - Elsevier
Background: Follicular lymphoma (FL) is an indolent, yet incurable disease, and patients
often require several lines of therapy throughout their lifetime (Batlevi et al. Blood Cancer J …
often require several lines of therapy throughout their lifetime (Batlevi et al. Blood Cancer J …
Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: A systematic literature review and meta-analysis.
S Kanters, BS Kahl, A Wiesinger, B Gurung… - 2021 - ascopubs.org
e19548 Background: Patients with follicular lymphoma (FL) can have high response rates to
early lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior …
early lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior …
[HTML][HTML] A Retrospective Cohort Study of Treatment Outcomes of Adult Patients with Relapsed or Refractory Low-Grade Follicular Lymphoma (ReCORD-FL)
G Salles, SJ Schuster, L Fischer, J Kuruvilla… - Blood, 2021 - Elsevier
Background: Novel therapies for multiply relapsed follicular lymphoma (FL) are often
evaluated in single arm trials with no comparative data on patients receiving usual care. This …
evaluated in single arm trials with no comparative data on patients receiving usual care. This …
Treatment sequencing and impact of number of treatment lines on survival in follicular lymphoma: A national population‐based study
T Wästerlid, CE Dietrich, A Oksanen, LD Spångberg… - …, 2024 - Wiley Online Library
Follicular lymphoma (FL) is a clinically heterogeneous disease. The need for treatment,
treatment sequencing, number of treatment lines, and its association with survival have not …
treatment sequencing, number of treatment lines, and its association with survival have not …
[HTML][HTML] A retrospective cohort study of treatment outcomes of adult patients with relapsed or refractory follicular lymphoma (ReCORD-FL)
G Salles, SJ Schuster, L Fischer, J Kuruvilla… - …, 2022 - journals.lww.com
This study (ReCORD-FL) sought to construct a historical control cohort to augment single-
arm trials in relapsed/refractory follicular lymphoma (r/r FL). A retrospective study in 10 …
arm trials in relapsed/refractory follicular lymphoma (r/r FL). A retrospective study in 10 …
[HTML][HTML] What is the best combination of first-line and salvage treatments in follicular lymphoma? Results of the multicenter study “Refoll” by the Fondazione Italiana …
Abstract Abstract 154 Background Follicular lymphoma (FL) has an indolent course during
which patients (pts) receive multiple lines of active treatments ranging from single-agent …
which patients (pts) receive multiple lines of active treatments ranging from single-agent …
Progression-free survival after front line, second line and third line in patients with follicular lymphoma treated in clinical practice
A Rajamäki, M Sorigue, REI Prusila, MEL Kuusisto… - 2024 - oulurepo.oulu.fi
Background: The modern-day therapeutic landscape for follicular lymphoma (FL) includes a
number of highly effective therapies. Patients and methods: We set out to determine …
number of highly effective therapies. Patients and methods: We set out to determine …
[HTML][HTML] Clinical outcomes in patients relapsed/refractory after≥ 2 prior lines of therapy for follicular lymphoma: a systematic literature review and meta-analysis
Background Patients with follicular lymphoma (FL) can have high response rates to early
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
lines of treatment. However, among FL patients relapsed/refractory (r/r) after≥ 2 prior lines …
相关搜索
- follicular lymphoma prior lines
- follicular lymphoma treatment outcomes
- clinical outcomes prior lines
- follicular lymphoma meta analysis
- follicular lymphoma clinical practice
- follicular lymphoma impact of number
- follicular lymphoma clinical outcomes
- follicular lymphoma later lines
- follicular lymphoma number of treatment lines
- follicular lymphoma treatment patterns
- follicular lymphoma salvage treatments
- follicular lymphoma treatment sequencing
- follicular lymphoma treatment selection